A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (original) (raw)

• Letter
• Published: 09 January 2007
• Kelly M McGarvey1,2,
• Xiaobing Yu3,
• Linzhao Cheng2,3,4,
• Kornel E Schuebel1,
• Leslie Cope4,
• Helai P Mohammad1,
• Wei Chen1,5,
• Vincent C Daniel1,
• Wayne Yu1,
• David M Berman6,
• Thomas Jenuwein7,
• Kevin Pruitt1,
• Saul J Sharkis1,2,
• D Neil Watkins1,
• James G Herman1,2 &
• …
• Stephen B Baylin1,2

Nature Genetics volume 39, pages 237–242 (2007)Cite this article

• 5752 Accesses
• 859 Citations
• 11 Altmetric
• Metrics details

Abstract

Adult cancers may derive from stem or early progenitor cells1,2. Epigenetic modulation of gene expression is essential for normal function of these early cells but is highly abnormal in cancers, which often show aberrant promoter CpG island hypermethylation and transcriptional silencing of tumor suppressor genes and pro-differentiation factors3,4,5. We find that for such genes, both normal and malignant embryonic cells generally lack the hypermethylation of DNA found in adult cancers. In embryonic stem cells, these genes are held in a 'transcription-ready' state mediated by a 'bivalent' promoter chromatin pattern consisting of the repressive mark, histone H3 methylated at Lys27 (H3K27) by Polycomb group proteins, plus the active mark, methylated H3K4. However, embryonic carcinoma cells add two key repressive marks, dimethylated H3K9 and trimethylated H3K9, both associated with DNA hypermethylation in adult cancers6,7,8. We hypothesize that cell chromatin patterns and transient silencing of these important regulatory genes in stem or progenitor cells may leave these genes vulnerable to aberrant DNA hypermethylation and heritable gene silencing during tumor initiation and progression.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

1. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983–3988 (2003).
   Article CAS PubMed PubMed Central Google Scholar
2. Clarke, M.F. & Fuller, M. Stem cells and cancer: two faces of eve. Cell 124, 1111–1115 (2006).
   Article CAS PubMed Google Scholar
3. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428 (2002).
   Article CAS PubMed Google Scholar
4. Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nat. Genet. 21, 163–167 (1999).
   Article CAS PubMed Google Scholar
5. Feinberg, A.P. & Tycko, B. The history of cancer epigenetics. Nat. Rev. Cancer 4, 143–153 (2004).
   Article CAS PubMed Google Scholar
6. McGarvey, K.M. et al. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66, 3541–3549 (2006).
   Article CAS PubMed Google Scholar
7. Kondo, Y., Shen, L. & Issa, J.P. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol. 23, 206–215 (2003).
   Article CAS PubMed PubMed Central Google Scholar
8. Nguyen, C.T. et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62, 6456–6461 (2002).
   CAS PubMed Google Scholar
9. Baylin, S.B. & Ohm, J.E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107–116 (2006).
   Article CAS PubMed Google Scholar
10. Andrews, D.F., III, Nemunaitis, J., Tompkins, C. & Singer, J.W. Effect of 5-azacytidine on gene expression in marrow stromal cells. Mol. Cell. Biol. 9, 2748–2751 (1989).
    Article CAS PubMed PubMed Central Google Scholar
11. Bernstein, B.E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006).
    Article CAS PubMed Google Scholar
12. Azuara, V. et al. Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8, 532–538 (2006).
    Article CAS PubMed Google Scholar
13. Ringrose, L. & Paro, R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413–443 (2004).
    Article CAS PubMed Google Scholar
14. Sparmann, A. & van Lohuizen, M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6, 846–856 (2006).
    Article CAS PubMed Google Scholar
15. Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439, 871–874 (2006).
    Article CAS PubMed Google Scholar
16. Kuzmichev, A. et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. USA 102, 1859–1864 (2005).
    Article CAS PubMed PubMed Central Google Scholar
17. Lee, T.I. et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125, 301–313 (2006).
    Article CAS PubMed PubMed Central Google Scholar
18. Boyer, L.A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349–353 (2006).
    Article CAS PubMed Google Scholar
19. Bracken, A.P., Dietrich, N., Pasini, D., Hansen, K.H. & Helin, K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 20, 1123–1136 (2006).
    Article CAS PubMed PubMed Central Google Scholar
20. Schotta, G. et al. A silencing pathway to induce H3–K9 and H4–K20 trimethylation at constitutive heterochromatin. Genes Dev. 18, 1251–1262 (2004).
    Article CAS PubMed PubMed Central Google Scholar
21. Tamaru, H. et al. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34, 75–79 (2003).
    Article CAS PubMed Google Scholar
22. Johnson, L., Cao, X. & Jacobsen, S. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr. Biol. 12, 1360–1367 (2002).
    Article CAS PubMed Google Scholar
23. Jackson, J.P. et al. Dimethylation of histone H3 lysine 9 is a critical mark for DNA methylation and gene silencing in Arabidopsis thaliana. Chromosoma 112, 308–315 (2004).
    Article CAS PubMed Google Scholar
24. Fahrner, J.A., Eguchi, S., Herman, J.G. & Baylin, S.B. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 62, 7213–7218 (2002).
    CAS PubMed Google Scholar
25. Liang, G. et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22, 480–491 (2002).
    Article CAS PubMed PubMed Central Google Scholar
26. Beachy, P.A., Karhadkar, S.S. & Berman, D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324–331 (2004).
    Article CAS PubMed Google Scholar
27. Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552–556 (2002).
    Article CAS PubMed Google Scholar
28. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821–9826 (1996).
    Article CAS PubMed PubMed Central Google Scholar
29. Pruitt, K. et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2, e40 (2006).
    Article PubMed PubMed Central Google Scholar

Download references

Acknowledgements

Special thanks to L. Meszler (Cell Imaging Core Facility, The Sidney Kimmel Comprehensive Cancer Center), P. Argani (Pathology Department, Johns Hopkins University) and G. Dimri (Northwestern University) for providing the Bmi1cDNA. The pBABE-puro retroviral construct was provided by G. Dimri (Northwestern University). This work was supported by US National Institutes of Health grants CA116160 to S.B.B. and HL073781 to L.C. and National Cancer Institute grant CA043318 to S.B.B.

Author information

Authors and Affiliations

1. Cancer Biology Division, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   Joyce E Ohm, Kelly M McGarvey, Kornel E Schuebel, Helai P Mohammad, Wei Chen, Vincent C Daniel, Wayne Yu, Kevin Pruitt, Saul J Sharkis, D Neil Watkins, James G Herman & Stephen B Baylin
2. Program in Cellular and Molecular Medicine, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   Kelly M McGarvey, Linzhao Cheng, Saul J Sharkis, James G Herman & Stephen B Baylin
3. Institute for Cell Engineering, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   Xiaobing Yu & Linzhao Cheng
4. Biometry and Clinical Trials Division, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   Linzhao Cheng & Leslie Cope
5. Program in Human Genetics and Molecular Biology, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   Wei Chen
6. Pathology Department, The Johns Hopkins University Medical Institutions, Baltimore, 21231, Maryland, USA
   David M Berman
7. Research Institute of Molecular Pathology, The Vienna Biocenter, Dr. Bohrgasse 7, Vienna, A-1030, Austria
   Thomas Jenuwein

Authors

1. Joyce E Ohm
   You can also search for this author inPubMed Google Scholar
2. Kelly M McGarvey
   You can also search for this author inPubMed Google Scholar
3. Xiaobing Yu
   You can also search for this author inPubMed Google Scholar
4. Linzhao Cheng
   You can also search for this author inPubMed Google Scholar
5. Kornel E Schuebel
   You can also search for this author inPubMed Google Scholar
6. Leslie Cope
   You can also search for this author inPubMed Google Scholar
7. Helai P Mohammad
   You can also search for this author inPubMed Google Scholar
8. Wei Chen
   You can also search for this author inPubMed Google Scholar
9. Vincent C Daniel
   You can also search for this author inPubMed Google Scholar
10. Wayne Yu
    You can also search for this author inPubMed Google Scholar
11. David M Berman
    You can also search for this author inPubMed Google Scholar
12. Thomas Jenuwein
    You can also search for this author inPubMed Google Scholar
13. Kevin Pruitt
    You can also search for this author inPubMed Google Scholar
14. Saul J Sharkis
    You can also search for this author inPubMed Google Scholar
15. D Neil Watkins
    You can also search for this author inPubMed Google Scholar
16. James G Herman
    You can also search for this author inPubMed Google Scholar
17. Stephen B Baylin
    You can also search for this author inPubMed Google Scholar

Contributions

J.E.O. and S.B.B. designed this study. J.O., K.M.M., X.Y., K.E.S., H.P.M.,W.C.,V.C.D. and K.P. contributed collaborative experimental results. L.C. and S.G.S. managed the growth and manipulation of ES cells. D.M.B. assisted with characterization of the teratocarcinoma cell explants. D.N.W. and J.G.H. assisted J.E.O. and S.B.B. with data analysis and preparation of the manuscript. L.C. and W.Y. helped with performance and interpretation of microarray results that contributed to the data. T.J. provided antibodies generated in his laboratory for most of the histone modifications studied by ChIP analysis.

Corresponding author

Correspondence toStephen B Baylin.

Ethics declarations

Competing interests

The commercial rights to the methylation-specific PCR (MSP) technique belong to Oncomethylome. S.B.B and J.G.H. serve as consultants to Oncomethylome and are entitled to royalties from any commercial use of this procedure.

Supplementary information

Supplementary Fig. 1

Model for how abnormal DNA methylation may be recruited to most tumor suppressor genes in adult cancer cells, reflecting a stem or progenitor cell of origin. (PDF 122 kb)

Supplementary Table 1

Literature references for DNA-hypermethylated genes from Figure 1. (PDF 70 kb)

Supplementary Table 2

PCR Primers and conditions. (PDF 31 kb)

Rights and permissions

About this article

Cite this article

Ohm, J., McGarvey, K., Yu, X. et al. A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.Nat Genet 39, 237–242 (2007). https://doi.org/10.1038/ng1972

Download citation

• Received: 01 December 2006
• Accepted: 04 January 2007
• Published: 09 January 2007
• Issue Date: 01 February 2007
• DOI: https://doi.org/10.1038/ng1972

This article is cited by